After having got its application in the production of guns, shoes, medical implants as well as food materials, the innovative 3D technology now finds a new arena of its utility—a 3D cannabis inhaler, called Syqe Inhaler.
The credit for the creation of the first ever cannabis intake tool goes to Syqe Medical—an Israeli medical firm. The company is of the view that, with the help of 3D printing, it can make the marijuana medical program more acceptable. After producing the pocket-size inhaler, with metered dose functionality, the firm believes that the product will bring revolution in the field of medical inhalers. Moreover, it will also be helpful for the doctors to prescribe cannabis who were worried about the way to administer the drug into the body of the patient. Another amazing thing about this 3D instrument is that it can easily develop a connection with a tablet or smart phone through the built-in WiFi support.
Owing to the inhaler’s ability to develop connection with a device, the issue of monitoring the dosage of cannabis also gets solved. Consequently, now it will enable both physicians and patients to calculate and administer a precise dosage of medical marijuana. Such a phenomenon will also help the medical researchers to find out optimum doses for different conditions by analyzing data about the administered quantity of the drug.
As reported by Plastics Today, 3D printers from the house of Stratasys, were used to print about 75% components of this unconventional medical inhaler. The use of these printers significantly boosted the process of manufacturing as compared with the traditional production mechanisms. Perry Davidson, CEO of Syqe Medical, pointed out that each of the 4 major parts of the instrument, including the chassis, shell, thermal housing and airway, was produced by using different types of materials. In this way, they were able to impart the inhaler with the desired qualities, like greater tolerance for heat, biological compatibility, clarity and rigidity.
Perry Davidson said that for majority of the processes involved in the production of the medical inhaler, they had to develop fresh machinery and equipment because no instruments were already available for this purpose. As he explained, there is no method in vogue today that involves the inhalation of measured dose of a botanical extract. According to him, the in house printing accounted for the production of over 50% of the jigs, measuring instruments and the production tools.
Presently, the inhaler is passing through experimental stages and, by 2015 it is expected to be there for home use.